tiprankstipranks
Trending News
More News >
Nolato AB Class B (NLTBF)
OTHER OTC:NLTBF

Nolato AB (NLTBF) Price & Analysis

Compare
3 Followers

NLTBF Stock Chart & Stats

$6.65
$0.27(5.41%)
At close: 4:00 PM EDT
$6.65
$0.27(5.41%)

Nolato AB News

NLTBF FAQ

What was Nolato AB Class B’s price range in the past 12 months?
Nolato AB Class B lowest stock price was $4.31 and its highest was $7.25 in the past 12 months.
    What is Nolato AB Class B’s market cap?
    Nolato AB Class B’s market cap is $1.59B.
      When is Nolato AB Class B’s upcoming earnings report date?
      Nolato AB Class B’s upcoming earnings report date is May 06, 2026 which is in 83 days.
        How were Nolato AB Class B’s earnings last quarter?
        Nolato AB Class B released its earnings results on Feb 05, 2026. The company reported $0.063 earnings per share for the quarter, missing the consensus estimate of $0.081 by -$0.018.
          Is Nolato AB Class B overvalued?
          According to Wall Street analysts Nolato AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nolato AB Class B pay dividends?
            Nolato AB Class B pays a Annually dividend of $0.158 which represents an annual dividend yield of 2.38%. See more information on Nolato AB Class B dividends here
              What is Nolato AB Class B’s EPS estimate?
              Nolato AB Class B’s EPS estimate is 0.08.
                How many shares outstanding does Nolato AB Class B have?
                Nolato AB Class B has 241,786,940 shares outstanding.
                  What happened to Nolato AB Class B’s price movement after its last earnings report?
                  Nolato AB Class B reported an EPS of $0.063 in its last earnings report, missing expectations of $0.081. Following the earnings report the stock price went same 0%.
                    Which hedge fund is a major shareholder of Nolato AB Class B?
                    Currently, no hedge funds are holding shares in NLTBF
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Nolato AB Class B

                      Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.

                      Nolato AB (NLTBF) Earnings & Revenues

                      NLTBF Company Deck

                      NLTBF Earnings Call

                      Q4 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Positive
                      The call conveyed a broadly positive strategic and financial picture for the full year—sales growth, a double-digit increase in operating profit for the year, improved margins, higher EPS, a larger dividend, strong cash generation, improved ROCE and notable sustainability achievements. Near-term Q4-specific headwinds (currency effects, start-up costs, year-end volume weakness and volatile precious metal prices) weighed on quarterly results and will partially carry into Q1 2026, but management characterized these as temporary and actionable (pricing adjustments, ongoing ramp-ups, and planned expansions). Overall, the highlights (annual profitability and margin improvement, medical growth, sustainability milestones and financial strength enabling M&A) outweigh the temporary lowlights.View all NLTBF earnings summaries
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Elekta AB
                      Vitrolife AB
                      AddLife AB
                      MedCap AB
                      Vimian Group AB

                      Ownership Overview

                      3.50%92.77%
                      Insiders
                      ― Other Institutional Investors
                      92.77% Public Companies and
                      Individual Investors

                      Options Prices

                      Currently, No data available
                      ---
                      Popular Stocks